144 related articles for article (PubMed ID: 8735627)
1. Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension.
Atucha NM; Ortíz MC; Martínez C; Quesada T; García-Estañ J
Br J Pharmacol; 1996 May; 118(2):277-82. PubMed ID: 8735627
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclic guanosine monophosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats.
Atucha NM; Ortíz MC; Fortepiani LA; Ruiz FM; Martínez C; García-Estañ J
Hepatology; 1998 Apr; 27(4):900-5. PubMed ID: 9580129
[TBL] [Abstract][Full Text] [Related]
3. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.
Wiest R; Tsai MH; Groszmann RJ
Gastroenterology; 2001 Mar; 120(4):975-83. PubMed ID: 11231951
[TBL] [Abstract][Full Text] [Related]
4. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Heinemann A; Stauber RE
J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis.
Atucha NM; Shah V; García-Cardeña G; Sessa WE; Groszmann RJ
Gastroenterology; 1996 Dec; 111(6):1627-32. PubMed ID: 8942743
[TBL] [Abstract][Full Text] [Related]
7. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension.
Chagneau C; Tazi KA; Heller J; Sogni P; Poirel O; Moreau R; Lebrec D
J Hepatol; 2000 Jul; 33(1):26-32. PubMed ID: 10905582
[TBL] [Abstract][Full Text] [Related]
8. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
Wiest R; Shah V; Sessa WC; Groszmann RJ
Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension.
Shah V; Wiest R; Garcia-Cardena G; Cadelina G; Groszmann RJ; Sessa WC
Am J Physiol; 1999 Aug; 277(2):G463-8. PubMed ID: 10444461
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension.
Iwakiri Y; Tsai MH; McCabe TJ; Gratton JP; Fulton D; Groszmann RJ; Sessa WC
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2084-90. PubMed ID: 12003815
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
[TBL] [Abstract][Full Text] [Related]
12. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide.
García-Estañ J; Atucha NM; Groszmann RJ
J Hepatol; 1996 Aug; 25(2):206-11. PubMed ID: 8878783
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 is responsible for hyperdynamic circulation in portal hypertensive rats.
Ai JH; Yang Z; Qiu FZ; Zhu T
World J Gastroenterol; 2003 Nov; 9(11):2544-7. PubMed ID: 14606093
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis.
Kanashiro CA; Cockrell KL; Alexander BT; Granger JP; Khalil RA
Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R295-303. PubMed ID: 10666128
[TBL] [Abstract][Full Text] [Related]
15. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade.
Sieber CC; Groszmann RJ
Am J Physiol; 1992 Jun; 262(6 Pt 1):G996-1001. PubMed ID: 1616049
[TBL] [Abstract][Full Text] [Related]
16. Male castration increases neuronal nitric oxide synthase activity in the rat mesenteric artery through protein kinase C activation.
Blanco-Rivero J; Balfagón G; Ferrer M
J Vasc Res; 2005; 42(6):526-34. PubMed ID: 16174988
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
18. Reduced capacitative calcium entry in the mesenteric vascular bed of bile duct-ligated rats.
Atucha NM; Nadal FJ; Alcaraz A; Iyú D; Ortiz MC; García-Estañ J
Eur J Pharmacol; 2005 Nov; 525(1-3):117-22. PubMed ID: 16266702
[TBL] [Abstract][Full Text] [Related]
19. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.
Fernandez M; Lambrecht RW; Bonkovsky HL
J Hepatol; 2001 Jun; 34(6):812-7. PubMed ID: 11451163
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C activation increases endothelial nitric oxide release in mesenteric arteries from orchidectomized rats.
Blanco-Rivero J; Sagredo A; Balfagón G; Ferrer M
J Endocrinol; 2007 Jan; 192(1):189-97. PubMed ID: 17210756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
